Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.


TSX:WELL - Post by User

Comment by jdsd0517on Dec 23, 2022 3:08pm
80 Views
Post# 35190221

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:NoShort - The Bottomless fool, The Tree Planter....

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:NoShort - The Bottomless fool, The Tree Planter....Not at all, and that just underlines how little of this you understand.

You can use either current cash flows, or future cash flows.  Depending on which you choose, then you can adjust the multiple accordingly.  Quite often, multiples are based on comparables and you use the same basis of EBITDA that was used to calculate the multiple on those comps.

Again, you need to better understand equity value, versus enterprise value, and how capital structure plays a role in the calculations.  You don't seem to have your head around this yet.

Just remember that the value of a company overall is independent of how it is financed (leaving aside bankruptcy risk for the moment).  After you calculate the value of the company, then you calculate how much of that value belongs to whom.

You keep getting the concepts of equity value and enterprise value mixed up.

You are right, though.  Your counterpoints aren't real dragons...more like mosquitoes.

Noshortsallowed wrote: So you acknowledge that when we use PRESENT cash flow amounts we aren't using FUTURE cash flows and discount from their (which essentially doesn't) account for future growth. You also acknowledge that you discount for debt but not for assets (and since their assets are double the amount of their debts - should we not be ADDING hundreds of millions rather than subtracting as you do in your calculations?). You also seem to acknowledge that the muliple assigned usually indicates a healthy buy.

slayed dragons? Please give me a break. You are so full of yourself.


<< Previous
Bullboard Posts
Next >>